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Elevated levels of the calcium-binding protein S100A4 are associated with poor patient survival in breast cancer patients and induce
metastasis in rodent models. To investigate the effects of S100A4 on different components of the metastatic process, epithelial cells
lines have been isolated from nonmalignant tumours in neu transgenic mice and from malignant tumours in neu/S100A4 double
transgenic mice. Additional cell lines expressing both Neu and S100A4 have also been derived by transfection of rat S100A4 cDNA
into tumour cell lines cloned from neu single transgenic mice. Using these cells in transfilter migration assays, it has been shown that
increases in either motility or invasive properties correlate with each other and with the level of S100A4 protein. Injection of three of
the cell lines separately into the mammary fat pads of nude mice showed that elevated levels of S100A4 correlated with the degree
of metastasis to the lungs. In contrast, changes in cell proliferation and cell–substrate adhesion did not correlate with S100A4 levels.
Neither motility nor invasiveness correlated with proteolytic degradation of gelatin as measured by zymography. Thus, the results
suggest that the main effect of increases in S100A4 levels in metastasis is to generate increased cell motility and invasion and that this
latter change is not dependent upon an increased ability to degrade the intercellular matrix.
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The processes by which solid primary tumours, such as those of
the breast, are able to disseminate and establish growth at a
secondary site are still poorly understood. Tumour metastasis is
complex, probably requiring both gain and loss of functions,
enabling escape from the primary tumour, and growth at a
secondary site. This has led to the search for metastasis-associated
genes, which, unlike oncogenes, are unable to initiate tumour
formation but are able to induce a metastatic phenotype in
previously tumorigenic cells (Davies et al, 1993, 1996; Oates et al,
1996). One such metastasis-associated gene is that for the calcium-
binding protein S100A4 (Barraclough et al, 1987). Increased levels
of S100A4 have been shown to induce a metastatic phenotype in
several rodent models of mammary carcinogenesis (Davies et al,
1993; Grigorian et al, 1996). Moreover, elevated expression of
S100A4 has been shown to correlate with early patient demise of
one group of breast cancer patients (Rudland et al, 2000),
presumably due to metastatic spread of the primary tumour.
A transgenic murine model that represents human metastatic
breast disease in both its pathology and development of metastasis
has previously been established by mating MMTV-neu transgenic
mice with S100A4 transgenic mice (Davies et al, 1996). The
resultant neu/S100A4 transgenic offspring develop both mammary
gland tumours and lung metastases, in contrast to the parental
transgenic MMTV-neu strain, which develops only mammary
gland tumours (Bouchard et al, 1989; Davies et al, 1996), and to the
S100A4 transgenic strain, which shows no pathology (Davies et al,
1995). Other transgenic murine models showing that overexpres-
sion of S100A4 causes metastasis have also been developed
(Ambartsumian et al, 1996). S100A4 has been shown to be capable
of binding to the actomyosin elements of the cellular cytoskeleton
(Davies et al, 1993; Kriajevska et al, 1994; Takenaga et al, 1994),
raising the possibility that the metastatic effect exerted by S100A4
might occur via its influence on cytoskeletal function, which in
turn may regulate cell movement. In this study, new mammary cell
lines have been derived from mice carrying transgenes for either
the neu oncogene alone, or the neu oncogene in combination with
that for S100A4. The behaviour of these cell lines, and that of the
neu oncogene containing cell lines transfected with the cDNA for
S100A4 in vitro have been compared using in vitro tests to study
individual aspects of S100A4-mediated effects for correlation with
in vivo phenotypes. In particular, the effect of S100A4 on
cytoskeletal-dependent processes, including motility and invasion,
as well as on other potential elements of the metastatic phenotype,
including metalloproteinase-mediated matrix disruption of an
artificial matrix, gelatin, have been examined.
MATERIALS AND METHODS
Isolation and characterisation of cell lines
Mixed cell populations were isolated from mammary gland tumour
extracts of either neu or neu/S100A4 transgenic mice (Davies et al,
1996), as described previously (Davies et al, 1993). Cells isolated
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sfrom tumour extracts were cloned and subsequently grown in
Routine Medium (Dulbecco’s modified Eagle’s medium (DMEM),
10% (vv
 1) foetal calf serum (FCS), 100ngml
 1 insulin, 50ngml
 1
hydrocortisone). The cells were tested for the expression of peanut
lectin-binding protein and cytokeratin 18 (Jenkinson, 2001), as
described previously for rat and human mammary cell lines
(Rudland et al, 1998). All the cell lines could be grown indefinitely
in routine medium and stocks were frozen in liquid nitrogen for
preservation. The characterisation and growth of the low S100A4-
expressing control cell line Rat mammary (Rama) 25 isolated from
a chemically induced rat mammary tumour has been described
previously (Bennett et al, 1978).
Transfection of S100A4 DNA into cultured cells isolated
from neu transgenic mice
For transfection, cell lines grown to approximately 60% confluence
in 3cm diameter dishes were transfected with 0.5mg of the
expression vector for S100A4, pSV2neo-p9Ka (S100A4) (Davies
et al, 1993) using the Lipofectamine system (Invitrogen Ltd,
Paisley, Scotland), following the manufacturer’s instructions. At
72h after transfection, the cells were passaged at a split ratio of
1:10 into Selective Medium, Routine Medium containing
0.5mgml
 1 Geneticin (G418). Cells were cultured in this Selective
Medium for 2 weeks, the medium being replaced every 2–3 days
and the resulting colonies for any one cell line pooled and
expanded. Incubation of control nontransfected cells with the
Selective Medium caused death of all the cells within 5 days.
Detection of Neu and S100A4 protein
For Western blotting, total cellular protein was isolated from cell
lines; washed twice with cold phosphate-buffered saline (PBS),
lysed in 100ml of 0.125 M Tris-HCl (pH 6.8), 4% (wv
 1) sodium
dodecyl sulphate (SDS), 20% (vv
 1) glycerol; scraped with a
rubber policeman, collected in 1.5ml tubes and protein quanti-
tated using Bradford’s reagent (Pierce and Warriner, Chester, UK)
following the manufacturer’s instructions. Samples (10mg) of
protein from each cell line in gel loading buffer (0.125 M Tris-HCl
(pH 6.8), 4% (wv
 1) SDS, 20% (vv
 1) glycerol, 0.04% (wv
 1)
bromophenol blue, 10% (vv
 1) 2-mercaptoethanol), heated to
1001C, were separated by electrophoresis on 10 or 15% (wv
 1)
polyacrylamide gels in the presence of SDS. The separated
polypeptides were transferred to nitrocellulose membranes and
incubated with a primary antibody to either c-erbB-2 (Dako Ltd,
Ely, Cambs, UK) or S100A4 (Gibbs et al, 1995), which were
detected, in turn, by means of a peroxidase-conjugated secondary
polyclonal antibody and visualised with the Supersignal Chemi-
luminescent System (Pierce and Warriner, Chester, UK). Western
blotting was performed with protein isolated from three indepen-
dent experiments. Bands were detected by autoradiography using
Fuji X-Omat autoradiography film and quantified by scanning the
images using a Shimadzu CS9000 scanning densitometer. Differ-
ences in loading were calculated by scanning and quantifying the
staining of each of the cell lines on the Coomassie blue stained
protein gel.
Cell substrate-adhesion assay
Cells were trypsinised and counted using a Coulter counter, and
resuspended at 2 10
5 cellsml
 1. Cell suspension (1ml) was
added to each well of a 24-well plate and at time periods of 0.5, 1,
1.5, 2.0, 2.5h, the number of adherent cells was found by washing
the wells three times with PBS to remove any cells in suspension.
Any cells adhering to the well were trypsinised and counted using
the Coulter counter. Each experiment was carried out in triplicate.
Cell proliferation assay
Cells were trypsinised and counted as described previously, and
resuspended at 1 10
4 cellsml
 1 and 1ml was added to each well
of a 24-well plate. The cells were incubated for 24, 48, 72h periods,
and at the end of each time period the number of cells was found
by trypsinising the cells and counting them in a Coulter counter.
Each experiment was carried out in triplicate.
Motility and invasion assays
The motile and invasive abilities of the cell lines through a filter
containing 8mm pores were measured using a Boyden chamber in
a 24-well plate assay system (Corning Costar, High Wycombe,
Bucks, UK). Chemotactic-induced motility in response to a FCS
concentration gradient was measured by adding 400ml of Routine
Medium containing 10% (vv
 1) FCS to the lower compartment,
and 2 10
5 cells in 200ml of Routine Medium, but with 2% (vv
 1)
FCS to the upper compartment of the Boyden chamber. The cells
were incubated for 24h, the upper side of the filter was wiped with
a cotton swab to remove any nonmotile cells, and the motile cells
on the lower side of the filter were fixed and stained using the
Diffquik histochemical stain (Dade Behring, Du ¨dingen, Switzer-
land) according to the manufacturer’s instructions. The lower
compartment of the Boyden chamber was checked for cells and the
number of stained cells/field of 0.50mm
2 on the lower side of the
filter was counted using a Dynascope with a  20 objective (Vision
Engineering, Woking, Surrey, UK). For each cell line, four
experiments were carried out, each experiment consisting of three
filters and 10 fields per filter were counted. In controls, fixed
numbers of cells incubated for different times up to 24h showed a
linear increase in the number of motile cells on the lower side of
the filter. Thereafter, there was an appreciable number of cells
present in the lower chamber.
For cell invasion, the filters were coated with 50mg Matrigel
(Collaborative Biomedical Products, Becton Dickinson, Oxford,
UK) and the experiments were carried out as for the chemotactic
motility assays. The number of invasive cells/field on the lower
side of the filters were determined as for the motility assays for
three experiments for each cell line.
Zymography
Cell lines were washed twice with PBS and incubated in 8ml of
growth medium consisting of phenol-red-free DMEM, 2% (vv
 1)
FCS, 200ngml
 1 insulin and 50ngml
 1 hydrocortisone for 48h.
The media were harvested from each of the cell lines, grown to
either 40–50% confluency (sparse cultures) or 80–90% confluency
(dense cultures) and any protein concentrated into a 1ml volume
or less using an Ultrafree-15 centrifugal filter unit (Biomax-5K,
Millipore, Watford, UK). The concentration of protein in each
sample was then determined by measuring the absorbance at
595nm using Bradford’s reagent (Pierce and Warriner, Chester,
UK) following the manufacturer’s instructions and relating it to the
absorbance found for standards containing a known concentration
of bovine serum albumin.
Conditioned medium was analysed on 10% (wv
 1) SDS
polyacrylamide resolving gels containing 1mgml
 1 of gelatin,
with 4% (wv
 1) polyacrylamide stacking gels using the Bio-Rad
Miniprotean system, as described previously (Heussen and
Dowdle, 1980). Briefly, molecular weight markers or samples
consisting of 2 or 20mg of conditioned medium in loading buffer
(0.4 M Tris-HCl (pH 6.8), 5% (wv
 1) SDS, 20% (wv
 1) glycerol,
0.03% (wv
 1) bromophenol blue) were loaded onto the gel,
without being heated and in the absence of 2-mercaptoethanol.
Gels were run at 41C until the dye front reached the anode end of
the gel. The resolving gel was washed for 2 30min in 2.5% (vv
 1)
Triton X-100 to remove the SDS from the gel. Following which the
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sgels were incubated for 18h at 371C in substrate buffer (50mM
Tris-HCl (pH 7.5), 10mM CaCl2,7 5 m M NaCl). The gel was
subsequently incubated in Coomassie blue stain for 1h and then
incubated in destain (45% (vv
 1) methanol, 5% (vv
 1) glacial
acetic acid) for 1h, until the digested bands in the gel became
clear. The gels were dried on gel drying frames between cellophane
sheets (Web Scientific, Crewe, Cheshire, UK).
Tumorigenicity studies and assays for metastasis
The 8Neu, 8Neup9Ka or PN2 cell lines were injected at 1 10
6 cells
in 0.1ml PBS into three groups of 20, 6-week-old female nude, nu-
nu mice, at a single subcutaneous site in the left inguinal
mammary fat pad. Mice were autopsied when tumours reached
approximately 10% of their body weight, and the tumours,
mammary glands, lymph nodes, lungs and any suspicious looking
tissues were fixed in Methacarn, processed and embedded in
paraffin wax as for the rat (Dunnington et al, 1983). Samples were
sectioned and stained with haematoxylin and eosin. Further
sections were immunocytochemically stained with antibodies to
either c-erbB-2 (Dako Ltd, Ely, Cambs, UK) or S100A4 (Gibbs et al,
1995), using a peroxidase-conjugated secondary antibody and
photographed using a Reichert Polyvar microscope, as described
previously (Davies et al, 1996). Sections of both lungs and lymph
nodes for each animal were examined for metastases. Animals
were maintained under UK Home Office Project Licence no. 40/
1515 to Professor PS Rudland, in accordance with the guidelines
set down by the United Kingdom Coordinating Committee for
Cancer Research (Workman et al, 1998).
RESULTS
Establishment of clonal cell lines
Cells were initially isolated from frozen samples of mammary
gland tumours from both neu and neu/S100A4 transgenic mice
(Materials and Methods). The tumours were selected from mice
representative of the general phenotype of the transgene status, as
demonstrated by haematoxylin and eosin-stained tumour sections.
Three permanently growing cell clones were established from the
mammary gland tumours of a neu transgenic mouse and termed
4Neu, 5Neu and 8Neu. Two permanently growing cell clones were
established from the mammary gland tumours of a bitransgenic
neu/S100A4 mouse and termed PN1 and PN2. The stable
transfection of the 4Neu and 8Neu clonal cell lines isolated from
the neu transgenic mouse with the rat pSV2neo-p9Ka (S100A4)
expression vector yielded two further cell lines obtained from the
pooled transfectant clones, termed 4Neup9Ka and 8Neup9Ka,
respectively, which grew in Geneticin-containing medium. Parallel
mock transfections without the expression vector yielded no
colonies after incubation of cells in Geneticin-containing medium.
All of the isolated cell lines were epithelial in nature as determined
by staining for epithelial lineage markers such as Cytokeratin 18
and peanut lectin-binding protein (not shown) (Jenkinson, 2001).
Each of the cell lines had a different expression profile for
S100A4 and Neu proteins, as determined by Western blotting
(Table 1, Figure 1). The S100A4 content of the mouse cell lines
varied from about a tenth to over three times that of the known low
S100A4-expressing control Rama 25 cell line isolated from a
dimethyl benzanthracene-induced rat mammary tumour. Cell lines
transfected with the S100A4 cDNA, 4Neup9Ka and 8Neup9Ka
showed a two to 12-fold increase in S100A4 compared to their
parental 4Neu and 8Neu cell lines (Student’s t-test, Po0.05). The
correct sized protein of apparent molecular weight 9kDa was seen
for all cell lines (Figure 1A). The Neu protein was expressed in all
of the mouse cell lines, there being about a two-fold difference
between the highest PN1 and lowest 4Neup9Ka cell lines. The
control Rama 25 cell line showed a level of endogenous Neu gene
expression significantly lower than all of the mouse cell lines
including 4Neup9Ka (Student’s t-test, Po0.05). The correct sized
protein of 185kDa was seen for all the cell lines, but an additional
band at 135kDa was sometimes seen; this may have been due to
crossreactivity with the EGF receptor (Figure 1C). The neu
transgene retained its activating transmembrane point mutation
at nucleotide position 2012, as determined by sequencing of PCR-
amplified mRNA isolated from the cell lines (Jenkinson, 2001).
Comparison of cell substrate-adhesion and proliferation
with S100A4 levels
Preliminary experiments showed that 0.5h after plating, 25–50%
of the total cells in the assay had adhered to the plastic substratum
and therefore 0.5h was taken as an appropriate time period over
which to measure rate of adhesion. The substrate adhesion of the
different cell lines varied. The percentage of total cells adhering at
0.5h was plotted against the levels of S100A4 protein (Figure 2A),
as determined by Western blotting, for each cell line. Cell adhesion
to plastic was found not to correlate significantly by least-squares
regression analysis with S100A4 protein levels (correlation
coefficient R
2¼0.23; probability points lie on a straight line,
P¼0.27) (Figure 2A), nor with Neu (R
2¼0.036; P¼0.71) protein
levels (Table 1).
The rate of cell proliferation measured during the exponential
phase of growth varied for each cell line. To examine whether cell
proliferation was associated with S100A4 expression, the rate of
cell proliferation was plotted against the protein levels of S100A4
as determined by Western blotting for each cell line (Figure 2B).
Cell proliferation rates did not correlate with levels of S100A4
protein by least-squares regression analysis (R
2¼0.002; P¼0.97)
(Figure 2B), although they did with levels of the Neu protein
(R
2¼0.6; P¼0.04) (data in Table 1).
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Figure 1 Detection of S100A4 and Neu protein in cell lines isolated
from mammary tumours of transgenic mice. Cellular protein extracts were
analysed by Western blotting for (A) S100A4 and (C) Neu protein on
SDS–polyacrylamide gels. Lanes 1, 2 and 3 contain 10mg of protein from
the cell lines isolated independently from a neu transgenic mammary gland
tumour: 4Neu, 5Neu and 8Neu. Lanes 4 and 5 contain 10mg of protein
from S100A4-transfected, neu-transgenic-derived cell lines: 4Neup9Ka and
8Neup9Ka. Lanes 6 and 7 contain 10mg of protein from cell lines isolated
from a neu/S100A4 bitransgenic mammary gland tumour: PN1 and PN2.
Lane 8 contains 10mg of protein from a low S100A4, low Neu-expressing
rat cell line: Rama 25. Coomassie blue staining of the protein on the SDS–
polyacrylamide gels is shown for the same gels as those immunocyto-
chemically stained for (B) S100A4 and for (D) c-erbB-2.
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sCell motility in vitro and levels of S100A4
Chemotactic motility was measured as described in Materials and
Methods. Motility was determined over a 24h period, a time
period, which was shown to ensure that all motile cells remained
attached to the lower side of the filter (Jenkinson, 2001). Cell
motility varied from about seven to nearly 130 migrating cells per
field (Table 1). Motility of the S100A4-transfected cell lines
4Neup9Ka, 8Neup9Ka was significantly higher than their respec-
tive parental cell lines 4Neu and 8Neu (Student’s t-test, Po0.03)
(Table 1). Moreover, the motilities of cell lines isolated from the
neu/S100A4 transgenic mice (PN1, PN2) were higher than those
isolated from neu transgenic mice (4Neu, 8Neu) (Table 1).
Comparison of S100A4 levels with cell motility for the different
cell lines showed that S100A4 levels and motility were closely
associated (Table 1). This difference in cell motility and S100A4
protein levels is significant when 8Neu is compared individually to
all the other cell lines (Student’s t-test, Po0.05). When S100A4
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Figure 2 Relationship between the levels of S100A4 protein, growth rate, substrate adhesion, cell motility, invasion and metastatic potential of the cell
lines. (A) substrate adhesion (adhesion); (B) growth rate; (C) motility and (D) invasion of each cell line are plotted against the relative levels of S100A4
protein. (E) Motility of each cell line is also plotted against its invasion. The data for the cell lines (4Neu, 5Neu, 8Neu, 4Neup9Ka, 8Neup9Ka, PN1, PN2) are
taken from Table 1. (F) Relative levels of S100A4 protein are plotted against the percentage of tumour-bearing mice with lung metastases for each of the
cell lines: 8Neu, 8Neup9Ka and PN2 (data taken from Table 2). Least-squares regression analysis of a fit of the points to a straight line yields for (A)
regression coefficient R
2¼0.23, probability P¼0.27; (B)R
2¼0.0002, P¼0.97; (C) R
2¼0.822, P¼0.012; (D) R
2¼0.765, P¼0.0022; (E) R
2¼0.950,
P¼0.00096; and (F) R
2¼0.996, P¼0.038.
Table 1 Expression levels of Neu, S100A4 proteins and invasive and motile behaviour of cell lines
Cell line
a
Neu protein
b
(arbitrary units)
S100A4 protein
c
(arbitrary units)
Adhesion
d
(%)
Growth rate
e
(cellsh
 1)
Motility
f
(cells per field)
Invasion
g
(cells per field)
5Neu 2.8370.42 1.1370.37 50.673.4 546718 N/D N/D
4Neu 3.2470.34 1.5970.37 30.872.8 2111713 40.8714.4 8.0873.52
4Neup9Ka 2.7570.45 3.1270.31
h 43.575.3 1058747 129719.8
h 25.872.21
h
8Neu 3.6470.70 0.0970.04 24.271.6 1104734 6.9573.71 3.2170.68
8Neup9Ka 5.5570.85 1.1370.18
h 32.975.2 28307183 29.576.6
h 10.771.92
h
PN1 5.8071.19 1.6670.18 56.171.3 2096749 75.0721.6 13.276.43
PN2 4.2070.54 1.8870.09 48.270.8 1730788 111746.0 23.871.98
i
aCell lines were isolated as described in Materials and Methods.
b,cRelative protein values for Neu and S100A4 are normalised to the low Neu-, low S100A4-expressing cell line
Rama 25, after correcting for differences in the Coomassie blue-stained protein gel, mean7s.e. of three experiments (Materials and Methods).
dCell substrate-adhesion was
measured at 0.5h and is expressed as a mean percentage of cells that had adhered7s.e. of three experiments for 2 10
5 cells plated.
eCell growth rate in cells per hour is the
mean7s.e. of three experiments for 1 10
4 cells plated.
fCell motility, average cells/field for 4 experiments7s.e. (Materials and Methods). Each experiment consisted of three
filters per cell line and 10 fields per filter were counted.
gCell invasion through Matrigel, average cells per field for three experiments7s.e. (Materials and Methods). Each
experiment consisted of three filters per cell line and 10 fields per filter were counted.
hSignificantly higher for the S100A4-transfected cell line compared to its parental cell line
(Student’s t-test, Pp0.03).
iSignificantly higher for the cell lines isolated from the double transgenic neu/S100A4 mice than the single transgenic neu mice (Student’s t-test,
Pp0.02). ND¼not determined, since this cell line had no S100A4-transfected derivative with which to compare motile and invasive abilities.
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sprotein levels are plotted against motility, there is a significant
linear relationship when assessed by a least-squares regression
analysis (R
2¼0.822; P¼0.012) (Figure 2C). In the case of Neu, no
correlation was found between cell motility and Neu protein levels
for the different cell lines, by least-squares regression analysis
(R
2¼0.0061; P¼0.88) (Table 1).
Cell invasion in vitro and levels of S100A4
To allow for direct comparison between cell invasion and cell
motility, the invasive abilities of the cell lines were measured using
the assay conditions optimised for the motility assay but with a
coating of Matrigel on the filter separating the upper and lower
compartment of the Boyden chamber. Using this assay, cell
invasion for the different cell lines varied from about three to
nearly 26 invading cells per field (Table 1). The invasive ability was
significantly higher in the S100A4 transfected cell lines 4Neup9Ka,
8Neup9Ka than their corresponding Neu parental cell lines 4Neu,
8Neu (Student’s t-test, Po0.03) (Table 1). Moreover, the invasive
abilities of cell lines isolated from the neu/S100A4 transgenic mice
(PN1, PN2) were higher than those isolated from neu transgenic
(4Neu, 8Neu), that for PN2 was significantly so (Student’s t-test,
Po0.02).
A close association was also observed between increasing
S100A4 protein levels and increasing invasive ability of the cell
lines (Table 1). All of the cell lines expressed a significantly higher
level of S100A4 protein than the 8Neu cell line (Student’s t-test,
Po0.01) and demonstrated a significantly higher invasive ability
when compared individually to 8Neu (Student’s t-test, Po0.01). A
significant linear correlation between S100A4 protein levels and
invasive ability was demonstrated by least-squares regression
analysis for each cell line (R
2¼0.765; P¼0.022) (Figure 2D).
However, the level of Neu protein was unrelated to the invasive
abilities of the cell lines, since increasing levels of Neu protein did
not correlate with increasing cell invasion (R
2¼0.0006; P¼0.96)
(Table 1).
To examine whether the invasive abilities of the cell lines
correlated with those of their motile properties, these two
parameters were compared for each cell line. A plot of cell motility
against cell invasion for six cell lines approximated to a straight
line and showed a strong correlation between these two parameters
using least-squares regression analysis (R
2¼0.95; P¼0.00096)
(Figure 2E). Interestingly, the 4Neu cell line and its S100A4-
transfected derivative cell line 4Neup9Ka showed the same five-
fold difference between motility and invasion, and the 8Neu cell
line and its derivative transfectant 8Neup9Ka showed a similar
difference between motility and invasion of 2.2- and 2.7-fold,
respectively (Table 1). It would therefore seem that the invasive
abilities of the cell lines through Matrigel are directly related to
their motile abilities in vitro.
Matrix metalloproteinase production and levels of S100A4
Matrix metalloproteinase (MMP) activities were measured by
gelatin zymography of conditioned media harvested from cell lines
grown in Routine Medium supplemented with 2% (vv
 1) FCS, the
same medium as that used in the upper chamber of the Boyden
system during the invasion assay. To analyse any effect of cell
confluency on MMP production, medium was harvested from
sparse cultures of cells, grown to 40–50% confluency and from
dense cultures of cells grown to 80–90% confluency.
Bands of lysed gelatin were detected in 2 and 20mg samples of
the conditioned medium of sparsely grown cultures (Figure 3A, B),
but no bands were present in the same amounts of conditioned
medium isolated from dense cell cultures (Figure 3C). Analysis of
2mg of protein from conditioned medium showed clear bands at a
size corresponding to proMMP9 (Mr 92kDa) and MMP9 (Mr
78kDa) (Figure 3A). A single band was seen at 67kDa, which
corresponds to the size of MMP2 (Figure 3A). When 20mgo f
protein from conditioned medium was analysed, the separation
between proMMP9 and MMP9 bands was lost and a large band of
lysis was also seen at a size corresponding to MMP2 (Figure 3B). In
sparse cultures, the amount of digestion was dependent on the
amount of total protein (compare Figure 3A and B). The molecular
mass of the lysed bands and the intensity of the bands of digestion
of the gelatin substrate was, however, the same for each cell line for
either 2 or 20mg of protein from conditioned medium. This result
provided semiquantitative evidence that each of the cell lines from
these sparse cultures produced approximately the same amount of
both pro and active MMPs. In contrast, conditioned medium from
the dense cultures contained no detectable pro or active MMPs
(Figure 3C). No attempt was made to measure MMP activity in
cells or cell membranes.
Incidence, metastatic ability and pathology of tumours
produced by selected cell lines
In all, one million cells from the low S100A4-expressing 8Neu cell
line, from the moderate S100A4 expressing 8Neup9Ka and from
the high S100A4-expressing PN2 cell line were injected into the
mammary fat pads of female nude mice. All mice produced
mammary gland tumours after a period of 2–3 weeks (100%
incidence) (Table 2).
The primary tumours consisted of chord-like structures
(Figure 4A) with varying amounts of spindle cells (Figure 4B),
but only the 8Neup9Ka and PN2 cell lines showed local invasion of
the muscle (Figure 4C) and produced lung metastases (Figure 4D)
(Table 2). For the moderate S100A4-expressing 8Neup9Ka cell line,
all of the lesions in the lung were classified as micrometastases, less
than 0.1mm in diameter. For the PN2 cell line, two mice produced
macrometastases, greater than 1mm in diameter, and the
remaining seven mice, which produced lesions in the lung, were
classified as micrometastases, as above (Table 2). The histology of
A
B
C 
205 kDa 
ProMMP9 (95 kDa)
MMP9 (78 kDa)
MMP2 (62 kDa) 
205 kDa 
ProMMP9/MMP9
(95/78 kDa)
MMP2 (62 kDa) 
4
N
e
u
 
 
8
N
e
u
 
 
4
N
e
u
p
9
K
a
8
N
e
u
p
9
K
a
P
N
1
 
 
P
N
2
 
205 kDa 
97.4 kDa 
66 kDa 
Figure 3 Zymogram analysis of matrix metalloproteinase production by
cell lines. Conditioned medium harvested from each cell line plated at a low
density for (A)2mg protein, (B)2 0mg protein, and at a high density for (C)
20mg protein was analysed by gelatin zymography for the presence of both
pro and active MMPs, as described in Materials and Methods.
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sthe lung metastases was similar to the primary with chords of cells
(Figure 4E), often with central necrosis for the larger lesions
(Figure 4E). Both the moderate S100A4-expressing 8Neup9Ka cell
line and the high S100A4-expressing PN2 cell line produced a
statistically significant greater number of lung metastases than the
low S100A4-expressing 8Neu cell line (Fisher’s exact test, Po0.03).
The incidence of metastasis in the high S100A4-expressing PN2
cell line was also greater than that in the moderate S100A4-
expressing 8Neup9Ka cell line, although not statistically significant
(Fisher’s exact test, P¼0.18). Furthermore, when the level of
S100A4 protein in the cultured cells was plotted against the
percentage of tumour-bearing mice with lung metastases, a
straight line could be drawn through the three points (least-
squares regression analysis R
2¼0.9965; P¼0.038) (Figure 2F). In
contrast, no such linear relationship occurred between the levels of
Neu protein and the percentage of mice with metastases (R
2¼0.18;
P¼0.72; graph not shown). Metastases were also observed in the
inguinal lymph nodes of some of the mice injected with the
8Neup9Ka and PN2 cell lines; however, these were not included in
any statistical analyses, since lymph node tissue was not available
from all of the injected mice.
Immunocytochemical staining for Neu showed that all three cell
lines 8Neu (Figure 5A), 8Neup9Ka and PN2 (Figure 5B) produced
strongly-staining primary tumours, even when they were pre-
dominantly composed of spindle cells (Figure 5C). Lymph node
metastases (Figure 5D), the micrometastases (Figure 5E) and the
macrometastases (Figure 5F) in the lungs were also stained
strongly for Neu. In contrast, immunocytochemical staining of
the same lesions for S100A4 depended on the identity of the cell
line injected into the nude mice. Thus, no staining for S100A4 was
seen in the tumours produced by the 8Neu cell line (Figure 5G).
The tumours produced by the 8Neup9Ka cell line showed a low to
moderate staining for S100A4 (Figure 5H), which varied within
each tumour. Tumours produced by the PN2 cell line showed
higher levels of staining for S100A4 than the tumours produced by
the other two cell lines, particularly for the spindle cell component
(Figure 5I, J). Immunocytochemical staining of the macrometas-
tases for S100A4 usually showed a stronger intensity of staining
than was present in the primary tumours (compare Figures 5K and
I), and all the micrometastases in the lungs were stained strongly
(Figure 5L). There was no immunocytochemical staining of
lymphocytes observed in the lymph nodes of the nude mice
(Figure 5K). Although no immunocytochemical staining for Neu or
S100A4 was found in the lung tissue of the nude mice bearing
mammary gland tumours produced by the 8Neu cell line (not
shown), clusters of stained cells forming micrometastases and even
single cells were readily discernable in the lungs of mice with
tumours produced by the 8Neup9Ka and PN2 cell lines (Figure 5E,
L). These results confirmed that the tumour cells observed in the
lungs were derived from the injected cell lines and not from the
parenchymal lung tissue, and that these cells had arisen from the
primary tumours and metastasised to the lungs.
DISCUSSION
Cell lines expressing elevated levels of S100A4 have been obtained
either by direct transfection of cell lines from mice carrying the
neu transgene or by isolation of cell lines from mice carrying both
the neu and the S100A4 transgenes. The former mice produce only
nonmetastatic tumours, while the latter mice produce metastatic
tumours (Davies et al, 1996). The establishment of these cell lines
expressing different levels of Neu and S100A4 has provided the
opportunity to examine the effects of different levels of these
proteins on cell behaviour in vitro, which may be related to
metastasis in vivo. There was no correlation between the levels of
S100A4 and cell-substrate adhesion to plastic substrata or
proliferation rates for this particular set of cell lines; cell–cell
Table 2 Incidence of mammary gland tumours and lung metastases in
nude mice injected with cell lines
Cell line
injected
a
Total number
of mice
b
Number of
mice with
mammary gland
tumours
c (%)
Number of
mice with
metastases
d (%)
8Neu 19 19 (100%) 0 (0%)
8Neup9Ka 20 20 (100% 6
e,f (30%)
PN2 19 19 (100%) 9
f,g (48%)
aCell lines representative of three different cell types, those isolated from neu
transgenic mice (8Neu), their S100A4-transfected derivatives (8Neup9Ka) and those
isolated from neu/S100A4 double transgenic mice (PN2) were injected into the
mammary fat pad of female nude mice.
bTotal number of mice injected for each cell
line.
cNumber of mice with palpable mammary gland tumours 3 weeks after
inoculation with cell lines; percentage of mice bearing tumours (%) is also shown.
dNumber of mice with metastases in the lungs; percentage of tumour-bearing mice
with metastases (%) is also shown.
eAll six of the lung metastases were classified as
micrometastases, o0.1mm diameter.
fSignificantly higher number of metastases than
the 8Neu cell line (Fisher’s exact test; 8Neup9Ka, P¼0.028; PN2, P¼0.005).
gTwo
of the lung metastases were classified as macrometastases 41mm diameter, and the
remaining seven lung metastases were classified as micrometastases o0.1mm
diameter.
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Figure 4 Histopathological appearance of cell lines growing as tumours
in nude mice. (A) Mammary tumour produced by PN2, showing chord-like
structures (c), surrounded by spindle cells (arrows). (B) Mammary tumour
produced by PN2, showing a predominant spindle cell component. (C)
Mammary tumour produced by 8Neup9Ka, showing invasion of muscle
(arrows). (D) Lung (l) macrometastasis produced by a PN2-derived
tumour, showing chord-like structures. (E) Higher magnification of PN2-
derived lung macrometastasis in (D) above, showing chord-like structures
with central necrosis (n).( F) Lymph node (l) metastasis produced by an
8Neup9Ka-derived tumour, showing chord-like structures with central
necrosis (n). Magnification, (A, B, C)  220; (D)  22; (E)  175; (F)
 55. Bars,( A, B, C, E)5 0mm; (D, F) 200mm.
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sadhesion was not measured. These data are the first to
demonstrate in a transgenic murine-derived tumour system that
S100A4 levels correlate positively in a linear fashion with cell
invasive ability through Matrigel in response to an FCS density
gradient. This result demonstrates also that S100A4 causes, either
directly or indirectly, the enhanced invasive ability in at least the
S100A4-transfected cell lines. In contrast, correlation of levels of
Neu protein with only proliferation rates and not with substrate
adhesion, motility or invasion is consistent with the expression of
the neu transgene causing the largely proliferative breast lesions
and noninvasive breast tumours observed in transgenic mice
(Davies et al, 1996) and rats (Davies et al, 1999). To exclude the
possibility that any correlations were obtained by chance with the
cell lines reported here (Table 1), the analyses were expanded to
include a further two cell lines with differing levels of Neu and
S100A4 from another neu transgenic mouse tumour. These
analyses still yielded the same significant correlations as before
(Jenkinson, 2001).
Whether production of S100A4 correlates with invasive ability
has remained equivocal. Previously, S100A4 had been shown to
correlate with the invasive ability in vitro of Lewis lung carcinoma
cell lines (Takenaga et al, 1994). However, in a previous murine
mammary gland-derived cell line system, S100A4 levels were found
not to correlate with invasive ability through Matrigel (Ford et al,
1995). In that system, invasive ability was observed for only one
S100A4-expressing cell line. Comparison of this invasive cell line
to the other S100A4-expressing, noninvasive cell lines in that
study, demonstrated that the invasive cell line was the only one to
possess proteolytic activity, at least in vitro (Ford et al, 1995).
Zymogram analysis of proteolytic activity in the cell lines isolated
here showed that MMP2 and MMP9 were secreted in both pro and
active forms at similar levels, in all of the cell lines, independently
of levels of S100A4. Thus, in our present system, S100A4 would
appear not to regulate cell invasion by increasing proteolytic
activity either in low- or high-density cultures. Since MMP activity
in membranous fractions was not measured, we cannot exclude the
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Figure 5 Immunocytochemical staining of mammary tumours and metastases produced in nude mice. (A) Mammary tumour produced by 8Neu,
showing strong cell surface staining of carcinoma cells for Neu (arrows). (B) Mammary tumour produced by PN2, showing strong staining of chords of
epithelial cells for Neu (e), the stromal fibroblasts (f) were unstained. (C) Mammary tumour produced by PN2, showing strong staining of spindle cells for
Neu. (D) Lymph node metastasis produced by an 8Neup9Ka-derived tumour, showing strong staining for Neu (m), but no staining of lymphoid cells (l).( E)
Lung micrometastasis produced by an 8Neup9Ka-derived tumour, showing strong staining for Neu (m), but no staining of parenchymal lung tissue (l).( F)
Lung metastasis produced by a PN2-derived tumour, showing strong staining for Neu (m), but no staining of lung parenchymal tissue (l).( G) Mammary
tumour produced by 8Neu, showing no staining above background for S100A4. (H) Mammary tumour produced by 8Neup9Ka showing low/moderate
staining for S100A4. (I) Mammary tumour produced by PN2, showing moderate staining of spindle cells for S100A4. (J) Higher magnification of a mammary
tumour produced by PN2 showing moderate/strong cytoplasmic staining for S100A4. (K) Lymph node metastasis produced by an 8Neup9Ka-derived
tumour, showing strong staining for S100A4 (m), but no staining of lymphocytes (l).( L) Lung micrometastasis, showing strong staining for S100A4 (m), but
no staining of lung parenchymal tissue (l). Magnification, (A, E, J)  550; (B, C, F, G, H, I, K, L)  220; (D)  22. Bars, 50mm; (A, E, J)2 5mm; 50mm; (B,
C, F, G, H, I, K, L); (D) 200mm.
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spossibility that differences in these activities occurred in our
systems and that these differences could be regulated by S100A4.
Matrix metalloproteinase production could, however, be regu-
lated in all of the cell lines by confluency in culture. Matrix
metalloproteinase activity was observed only in the conditioned
medium of sparsely plated cells. It would therefore seem that
complete cell–cell contact provides an inhibitory extracellular
signal, which prevents MMP production/secretion in these cells.
Previous studies have also demonstrated that proteolytic activity is
dependent on cell density. For example, in the media of sparse
astrocytoma cells, more collagenase activity was seen than in dense
cultures (Tamaki et al, 1996), and in epidermoid carcinoma cells,
MMP9 secretion was detected only in sparse cultures (Xie et al,
1994). Furthermore, MMP2 binding to the cell surface of breast
carcinoma cells was detected only in low-density cultures (Menashi
et al, 1998). The most likely explanation for this observation would
be self-preservation of the tumour, as MMP production in a tight
mass of tumour cells would possibly lead to tumour cell
degradation. The findings reported here are, therefore, in
accordance with those of the Lewis lung carcinoma cell line model
described above, where MMP9 was produced in all of the cell lines,
independently of the level of S100A4 (Takenaga et al, 1994), but
contrast with studies in an osteosarcoma cell system which
implicated S100A4 in the control of both the levels of MMPs and
of the tissue inhibitors of matrix metalloproteinases (TIMPs)
(Bjornland et al, 1999). In the latter system, the reduction in
S100A4 expression in these cells resulted in downregulation of
mRNA levels for MMP2, MT-MMP1 and TIMP-1, and upregulation
of TIMP-2. The levels of TIMPs produced in the cell system
isolated and characterised in this study have not been examined.
Thus, it is still possible that TIMPs may be differentially expressed
in our cell lines and thereby inhibit MMP activity to a different
extent in each of the cell lines, although their role in vivo is more
complex (Hayakawa et al, 1992; Sato et al, 1994; Ree et al, 1997;
Yoshiji et al, 1998; Remacle et al, 2000).
In contrast to gelatinase activity, motility, a second major
component of invasion examined in vitro, showed a strong linear
correlation with levels of S100A4 protein in the different cell lines.
The stimulus for motility did not need to be directional, since
chemotactic and chemokinetic stimuli provided by 10% FCS,
induced the same degree of motility (Jenkinson, 2001). However,
2% FCS was only able to stimulate minimal motility of the cell lines
(Jenkinson, 2001), suggesting that a threshold level of motility-
stimulating molecules are probably required for cell motility.
These results in vitro suggest that an appropriate and sufficient
chemical stimulus is probably required for cell migration in vivo.
The results demonstrated here are in accordance with previous
findings in other cell systems that increased S100A4 levels results
in increased cell motility (Takenaga et al, 1994; Ford et al, 1995). A
significant linear correlation between S100A4 and cell motility,
however, has only been previously demonstrated in the Lewis lung
carcinoma cell system by measuring the phagocytic tracks of cells
in the absence of a chemotactic stimuli (Takenaga et al, 1994). The
results presented in this study are, therefore, the first to
demonstrate in a mammary tumour cell system, that cell motility
correlates with levels of S100A4 in a statistically significant linear
fashion and that, at least in the transfected cell lines, S100A4 is the
cause of this change. Furthermore, cell motility was shown to
correlate strongly with cell invasion. The fact that the gradient of
the plot of S100A4 against motility is about five times that of the
plot of S100A4 against invasion (Figure 2C, D) suggests that the
same cells are having to penetrate a more resistant barrier.
However, since both plots are linear and the plot of invasion
against motility is also linear with a similar gradient (Figure 4E),
the three parameters are likely to be closely related. It is therefore
probable that S100A4-induced increases in invasive ability are a
result of S100A4-driven cell motility in the cell lines under study.
The requirement for proteolytic activity for successful cell invasion
should not, however, be underestimated, since previous reports
have shown that high S100A4-expressing mammary tumour cell
lines, which were shown to be motile in vitro, were not invasive in
vitro or in vivo, due to a lack of MMP production (Ford et al,
1995). This difference may reflect differences between the two
mouse mammary systems under study. The transgenic mouse
system reported here may produce sufficient levels of MMPs for
motility to be rate limiting for invasion, whereas for the mouse
system of Ford et al (1995) this is not the case.
The mechanisms whereby S100A4 modulates cell motility are
unknown. However, S100A4 is known to bind to various
components of the actin–myosin cytoskeleton (Watanabe et al,
1993; Kriajevska et al, 1994; Takenaga et al, 1994). In addition,
recent advances in DNA microarray technology have led to the
isolation of several other metastasis-associated genes, many of the
products of which are associated with the cellular cytoskeleton
(Khanna et al, 2001) and its regulation (Clark et al, 2000). The
ability of S100A4 to bind and thereby regulate the phosphorylation
of nonmuscle myosin heavy chain in vitro (Kriajevska et al, 2000),
inter alia (Chen et al, 2001), may indicate that S100A4 plays a role
in regulating cellular dynamics. A precedent has already been set
for myosin phosphorylation as a mechanism of regulating cell
motility. The Rho family of small GTPase proteins regulates
motility by regulating actin–myosin dynamics via phosphoryla-
tion of both the myosin heavy and light chains (Amano et al, 1996;
Kimura et al, 1996). The Rho family has, however, been fairly
extensively studied in the context of cell motility, while relatively
little is known, as yet, about the effector mechanisms of S100A4
and other metastasis-related proteins in mediating motility.
The tumorigenic and metastatic abilities of the cell lines were
examined in the immunoincompetent, nude mouse, without the
complication of an immune response. The isolation and culture of
tumour cells from both neu and neu/S100A4 transgenic mice
increased the efficiency of mammary tumour production from 44
and 68% as seen after 14 months in neu and neu/S100A4
transgenic mice (Davies et al, 1996), respectively, to 100% in the
nude mice for all of the injected cell lines. This increase in
efficiency of production of primary tumours was probably due to
the following reasons. Firstly, constitutive expression of neu was
observed in the cell lines. There was no requirement to add
hormones in vitro or to mate in vivo to stimulate the expression of
neu, whereas in the original transgenic mice the neu transgene
requires the hormones of pregnancy to activate its MMTV
promoter (Bouchard et al, 1989; Davies et al, 1996). Secondly, in
the neu transgenic mice all of the epithelial cells express the neu
transgene, but only some cells are able to form tumours. This latter
result indicates that a second genetic change is required, in
addition to expression of the activated neu transgene, to allow
tumour formation. One possible explanation is the high level of the
loss of heterozygosity, a fact which may be related to the loss of
tumour suppressor genes, which has previously been observed in
these neu transgenic mice (Cool and Jolicoeur, 1999). Since cell–
cell adhesion was not measured, the possible role of E-cadherin as
a tumour suppressor in these systems is unknown. Whatever the
change required, this event had clearly taken place in the tumours
from which the cell lines were isolated.
The frequency of tumour metastasis, however, remained the
same in the neu/S100A4 tumour-derived PN2 cell line as in the
neu/S100A4 transgenic mice, with only 50% of mice with
mammary gland tumours developing lung metastases. The
efficiency of tumour metastasis for the 8Neup9Ka cell line was
lower, with only 30% of mice with mammary gland tumours
developing lung metastases. The 8Neu cell line developed no lung
metastases. These in vivo results follow the same pattern observed
for the cell lines in in vitro assays, where the 8Neu cell line had a
low level, the 8Neup9Ka cell line a moderate level, and the PN2 cell
line a high level of both motility and invasion. Confirmation that
these metastases are derived from the neu/S100A4-expressing
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smammary gland tumours is obtained by positive staining of these
metastases for both Neu and S100A4. The level of metastasis
expressed as a percentage of afflicted animals was found to be
positively correlated with the level of S100A4, but not with the level
of Neu protein in the cell lines, albeit for only three of the cell lines.
Metastasis in these Neu-expressing cell lines is therefore clearly
dependent, either directly or indirectly, on the level of S100A4
protein.
In this transgenic mouse model system, neu acts as an oncogene
producing neoplastic transformation of the targeted mammary
epithelial cells in vivo (Davies et al, 1996) and thereby enables
immortalised mammary epithelial cell lines to be established
in culture, as described in this report. Without overexpression
of neu these cells remain normal and cannot be grown in culture
(Jenkinson, 2001) without additional immortalising events.
The tumours produced by the neu transgenic mice (Davies et al,
1996) or by a derived mammary epithelial cell line, when
reintroduced into mice, are indolent and do not metastasise.
These results are consistent with the correlation between the levels
of Neu protein in the different cell lines and their growth rates in
culture, but not with other properties measured including
metastasising ability in vivo. Tissues of transgenic mice over-
expressing S100A4, on the other hand, fail to undergo neoplastic
transformation and that includes those of the mammary gland
(Davies et al, 1995). However in neu-transformed neoplastic
immortalised mammary cell lines, in vitro studies demonstrate
that S100A4 levels correlate well with cell invasion and that S100A4
mediates, either directly or indirectly, this invasion through its
ability to induce cell motility, at least in the transfected cells. It
therefore seems probable that S100A4-driven cell motility mediates
invasion in vivo and thereby metastasis in vivo, at least in this
particular model system.
ACKNOWLEDGEMENTS
We thank Mrs Angela Platt-Higgins for excellent technical
assistance in undertaking the histology and immunocytochemis-
try, the GlaxoWellcome Plc for a studentship to SRJ and the Cancer
and Polio Research Fund Ltd for additional consumables support.
REFERENCES
Amano M, Ito M, Kimura K, Fukata Y, Chihara K, Nakano T,
Matsuura Y, Kaibuchi K (1996) Phosphorylation and activation of
myosin by Rho-associated kinase (Rho-kinase). J Biol Chem 271:
20246–20249
Ambartsumian N, Grigorian M, Larsen F, Karlstrom O, Sidenius N, Rygaard
J, Georgiev G, Lukanidin E (1996) Metastasis of mammary carcinomas in
GRS/A hybrid mice transgenic for the mtsl gene. Oncogene 13:
1621–1630
Barraclough R, Savin J, Dube SK, Rudland PS (1987) Molecular cloning and
sequence of the gene for p9Ka. A cultured myoepithelial cell protein with
strong homology to S-100, a calcium-binding protein. J Mol Biol 198:
13–20
Bennett DC, Peachey LA, Durbin H, Rudland PS (1978) A possible
mammary stem cell line. Cell 15: 283–298
Bjornland K, Winberg JO, Odegaard OT, Hovig E, Loennechen T, Aasen
AO, Fodstad O, Maelandsmo GM (1999) S100A4 involvement in
metastasis: deregulation of matrix metalloproteinases and tissue
inhibitors of matrix metalloproteinases in osteosarcoma cells transfected
with an anti-S100A4 ribozyme. Cancer Res 59: 4702–4708
Bouchard L, Lamarre L, Tremblay PJ, Jolicoeur P (1989) Stochastic
appearance of mammary tumors in transgenic mice carrying the MMTV/
c-neu oncogene. Cell 57: 931–936
Chen H, Fernig DG, Rudland PS, Sparks A, Wilkinson MC, Barraclough R
(2001) Binding to intracellular targets of the metastasis-inducing
protein, S100A4 (p9Ka). Biochem Biophys Res Commun 286:
1212–1217
Clark EA, Golub TR, Lander ES, Hynes RO (2000) Genomic analysis of
metastasis reveals an essential role for RhoC. Nature 406: 532–535
Cool M, Jolicoeur P (1999) Elevated frequency of loss of heterozygosity in
mammary tumors arising in mouse mammary tumor virus/neu
transgenic mice. Cancer Res 59: 2438–2444
Davies BR, Davies MP, Gibbs FE, Barraclough R, Rudland PS (1993)
Induction of the metastatic phenotype by transfection of a benign rat
mammary epithelial cell line with the gene for p9Ka, a rat calcium-
binding protein, but not with the oncogene EJ-ras-1. Oncogene 8:
999–1008
Davies BR, Platt-Higgins AM, Schmidt G, Rudland PS (1999) Development
of hyperplasias, preneoplasias, and mammary tumors in MMTV-c-erbB-
2 and MMTV-TGFalpha transgenic rats. Am J Pathol 155: 303–314
Davies M, Harris S, Rudland P, Barraclough R (1995) Expression of the rat,
S-100-related, calcium-binding protein gene, p9Ka, in transgenic mice
demonstrates different patterns of expression between these two species.
DNA Cell Biol 14: 825–832
Davies MP, Rudland PS, Robertson L, Parry EW, Jolicoeur P, Barraclough R
(1996) Expression of the calcium-binding protein S100A4 (p9Ka) in
MMTV-neu transgenic mice induces metastasis of mammary tumours.
Oncogene 13: 1631–1637
Dunnington DJ, Hughes CM, Monaghan P, Rudland PS (1983) Phenotypic
instability of rat mammary tumor epithelial cells. J Natl Cancer Inst 71:
1227–1240
Ford HL, Salim MM, Chakravarty R, Aluiddin V, Zain SB (1995) Expression
of Mts1, a metastasis-associated gene, increases motility but not invasion
of a nonmetastatic mouse mammary adenocarcinoma cell line. Oncogene
11: 2067–2075
Gibbs FE, Barraclough R, Platt-Higgins A, Rudland PS, Wilkinson MC,
Parry EW (1995) Immunocytochemical distribution of the calcium-
binding protein p9Ka in normal rat tissues: variation in the cellular
location in different tissues. J Histochem Cytochem 43: 169–180
Grigorian M, Ambartsumian N, Lykkesfeldt AE, Bastholm L, Elling F,
Georgiev G, Lukanidin E (1996) Effect of mts1 (S100A4) expression on
the progression of human breast cancer cells. Int J Cancer 67: 831–841
Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K (1992) Growth-
promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1)
for a wide range of cells. A possible new growth factor in serum. FEBS
Lett 298: 29–32
Heussen C, Dowdle EB (1980) Electrophoretic analysis of plasminogen
activators in polyacrylamide gels containing sodium dodecyl sulfate and
copolymerized substrates. Anal Biochem 102: 196–202
Jenkinson SR (2001) In Vitro Models to Study the Role of S100A4 in
Mammary Epithelial Cell Metastasis. Liverpool, UK: University of
Liverpool
Khanna C, Khan J, Nguyen P, Prehn J, Caylor J, Yeung C, Trepel J, Meltzer
P, Helman L (2001) Metastasis-associated differences in gene expression
in a murine model of osteosarcoma. Cancer Res 61: 3750–3759
Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M, Yamamori
B, Feng J, Nakano T, Okawa K, Iwamatsu A, Kaibuchi K (1996)
Regulation of myosin phosphatase by Rho and Rho-associated kinase
(Rho-kinase). Science 273: 245–248
Kriajevska M, Bronstein IB, Scott DJ, Tarabykina S, Fischer-Larsen M,
Issinger O, Lukanidin E (2000) Metastasis-associated protein Mts1
(S100A4) inhibits CK2-mediated phosphorylation and self-assembly of
the heavy chain of nonmuscle myosin. Biochim Biophys Acta 1498: 252–
263
Kriajevska MV, Cardenas MN, Grigorian MS, Ambartsumian NS, Georgiev
GP, Lukanidin EM (1994) Non-muscle myosin heavy chain as a possible
target for protein encoded by metastasis-related mts-1 gene. J Biol Chem
269: 19679–19682
Menashi S, Dehem M, Souliac I, Legrand Y, Fridman R (1998)
Density-dependent regulation of cell-surface association of matrix
metalloproteinase-2 (MMP-2) in breast-carcinoma cells. Int J Cancer
75: 259–265
Oates AJ, Barraclough R, Rudland PS (1996) The identification of
metastasis-related gene products in a rodent mammary tumour model.
Biochem Soc Trans 24: 353S
S100A4 and invasion
SR Jenkinson et al
261
British Journal of Cancer (2004) 90(1), 253–262 & 2004 Cancer Research UK
E
x
p
e
r
i
m
e
n
t
a
l
T
h
e
r
a
p
e
u
t
i
c
sRee AH, Florenes VA, Berg JP, Maelandsmo GM, Nesland JM, Fodstad O
(1997) High levels of messenger RNAs for tissue inhibitors of
metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas
are associated with development of distant metastases. Clin Cancer Res 3:
1623–1628
Remacle A, McCarthy K, Noel A, Maguire T, McDermott E, O’Higgins N,
Foidart JM, Duffy MJ (2000) High levels of TIMP-2 correlate with adverse
prognosis in breast cancer. Int J Cancer 89: 118–121
Rudland PS, Barraclough R, Fernig DG, Smith JA (1998) Growth and
Differentiation of the Normal Mammary Gland and its Tumours. In:
Mammary Development and Cancer. London: Portland Press
Rudland PS, Platt-Higgins A, Renshaw C, West CR, Winstanley JH,
Robertson L, Barraclough R (2000) Prognostic significance of the
metastasis-inducing protein S100A4 (p9Ka) in human breast cancer.
Cancer Res 60: 1595–1603
Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M
(1994) A matrix metalloproteinase expressed on the surface of invasive
tumour cells. Nature 370: 61–65
Takenaga K, Nakamura Y, Endo H, Sakiyama S (1994) Involvement of
S100-related calcium-binding protein pEL98 (or mts1) in cell motility
and tumor cell invasion. Jpn J Cancer Res 85: 831–839
Tamaki M, McDonald W, Del Maestro RF (1996) Release of collagen type IV
degrading activity from C6 astrocytoma cells and cell density. J
Neurosurg 84: 1013–1019
Watanabe Y, Usada N, Minami H, Morita T, Tsugane S, Ishikawa R,
Kohama K, Tomida Y, Hidaka H (1993) Calvasculin, as a factor affecting
the microfilament assemblies in rat fibroblasts transfected by src gene.
FEBS Lett 324: 51–55
Workman P, Twentyman P, Balkwill F, Bahrain A, Chaplin D,
Double J, Embleton J, Newell D, Raymond R, Stables J, Stephens T,
Wallace J (1998) United Kingdom Co-ordinating Committee on
Cancer Research (UKCCCR) Guidelines for the Welfare of
Animals in Experimental Neoplasia (Second Edition). Br J Cancer 77:
1–10
Xie B, Bucana CD, Fidler IJ (1994) Density-dependent induction of 92-kd
type IV collagenase activity in cultures of A431 human epidermoid
carcinoma cells. Am J Pathol 144: 1058–1067
Yoshiji H, Harris SR, Raso E, Gomez DE, Lindsay CK, Shibuya M,
Sinha CC, Thorgeirsson UP (1998) Mammary carcinoma cells
over-expressing tissue inhibitor of metalloproteinases-1 show
enhanced vascular endothelial growth factor expression. Int J Cancer
75: 81–87
S100A4 and invasion
SR Jenkinson et al
262
British Journal of Cancer (2004) 90(1), 253–262 & 2004 Cancer Research UK
E
x
p
e
r
i
m
e
n
t
a
l
T
h
e
r
a
p
e
u
t
i
c
s